ID

39299

Descrição

Concomitant Chemo-radiotherapy Followed by MIDLE Chemotherapy in Stage I/II Extranodal NK/T-cell Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT01238159

Link

https://clinicaltrials.gov/show/NCT01238159

Palavras-chave

Versões (1)
  1. 17/12/2019 17/12/2019 -
Titular dos direitos

See clinicaltrials.gov

Transferido a

17 de dezembro de 2019

DOI

Para um pedido faça login.

Licença

Creative Commons BY 4.0
Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Voltar para os comentários do modelo
Comentários do grupo de itens para :

Comentários do item para :

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

Eligibility Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-Type NCT01238159

Inglês

Eligibility Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-Type NCT01238159

1 Formulários  
Inclusion Criteria
Descrição

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients were required to have a biopsy-proven diagnosis of nasal enktl
Descrição

Nasal Type Extranodal NK/T-Cell Lymphoma Biopsy

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0392788
UMLS CUI [1,2]
C0005558
at least 18 years old
Descrição

Age

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0001779
ann arbor stage ie or iie
Descrição

Ann Arbor lymphoma staging system

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0432516
measurable disease
Descrição

Measurable Disease

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1513041
eastern cooperative oncology group (ecog) performance status of 0-2 life expectancy greater than 12 weeks
Descrição

ECOG performance status | Life Expectancy

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1520224
UMLS CUI [2]
C0023671
adequate hematologic (hemoglobin > 9.0 g/dl, absolute neutrophil count > 1,500/ul and platelets > 100,000/ul)
Descrição

Hematologic function | Hemoglobin measurement | Absolute neutrophil count | Platelet Count measurement

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0221130
UMLS CUI [2]
C0518015
UMLS CUI [3]
C0948762
UMLS CUI [4]
C0032181
renal (serum creatinine < 1.5 mg/dl, creatinine clearance > 50 ml/min)
Descrição

Renal function | Creatinine measurement, serum | Creatinine clearance measurement

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0232804
UMLS CUI [2]
C0201976
UMLS CUI [3]
C0373595
hepatic (total bilirubin < 2 times of upper limit of normal and aspartate transferase < 3 times of upper limit of normal) function
Descrição

Liver function | Serum total bilirubin measurement | Aspartate aminotransferase measurement

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0232741
UMLS CUI [2]
C1278039
UMLS CUI [3]
C0201899
diagnosis of enktl is based on the presence of histological features and immunophenotypes compatible with enktl (e.g., cytoplasmic cd3+, cd20-, cd56+,
Descrição

Feature Histologic Compatible with Nasal Type Extranodal NK/T-Cell Lymphoma | Immunophenotype Histologic Compatible with Nasal Type Extranodal NK/T-Cell Lymphoma | Cytoplasmic CD3 Positive | CD20 Negative | CD56 Positive

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C2348519
UMLS CUI [1,2]
C0205462
UMLS CUI [1,3]
C0332290
UMLS CUI [1,4]
C0392788
UMLS CUI [2,1]
C0079611
UMLS CUI [2,2]
C0205462
UMLS CUI [2,3]
C0332290
UMLS CUI [2,4]
C0392788
UMLS CUI [3,1]
C3176950
UMLS CUI [3,2]
C1514241
UMLS CUI [4,1]
C0054946
UMLS CUI [4,2]
C1513916
UMLS CUI [5,1]
C0108754
UMLS CUI [5,2]
C1514241
positive for cytotoxic molecules
Descrição

Positive Finding Molecule cytotoxic

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C1514241
UMLS CUI [1,2]
C0567416
UMLS CUI [1,3]
C1511636
positive for ebv by in situ hybridization).
Descrição

Positive Finding Epstein-Barr Virus In Situ Hybridization

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C1514241
UMLS CUI [1,2]
C0014644
UMLS CUI [1,3]
C0162788
informed consent
Descrição

Informed Consent

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Descrição

Exclusion Criteria

Alias
UMLS CUI
C0680251
prior or concomitant malignant tumors
Descrição

Malignant Neoplasms

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0006826
any coexisting medical problems of sufficient severity to prevent full compliance with the study protocol.
Descrição

Medical Problem Preventing Protocol Compliance

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C1254481
UMLS CUI [1,2]
C1292733
UMLS CUI [1,3]
C0525058
enktl with non-nasal sites such as skin or gastrointestinal tract was excluded even if it is localized.
Descrição

Nasal Type Extranodal NK/T-Cell Lymphoma In addition to Anatomic Site Other | Nasal Type Extranodal NK/T-Cell Lymphoma In addition to Skin | Nasal Type Extranodal NK/T-Cell Lymphoma In addition to Gastrointestinal tract

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0392788
UMLS CUI [1,2]
C0332287
UMLS CUI [1,3]
C1515974
UMLS CUI [1,4]
C0205394
UMLS CUI [2,1]
C0392788
UMLS CUI [2,2]
C0332287
UMLS CUI [2,3]
C1123023
UMLS CUI [3,1]
C0392788
UMLS CUI [3,2]
C0332287
UMLS CUI [3,3]
C0017189
other subtypes of non-hodgkin lymphoma (nhl), including myeloid/nk cell precursor acute leukemia, blastic nk cell lymphoma/precursor nk cell lymphoblastic leukemia, aggressive nk cell leukemia, and peripheral t cell lymphoma, unspecified, were excluded.
Descrição

Non-Hodgkin Lymphoma Subtype Other | Blastic NK-cell lymphoma | Natural Killer Cell Lymphoblastic Leukemia/Lymphoma | Aggressive natural killer-cell leukemia | Peripheral T-Cell Lymphoma

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0024305
UMLS CUI [1,2]
C0449560
UMLS CUI [1,3]
C0205394
UMLS CUI [2]
C1301363
UMLS CUI [3]
C2826059
UMLS CUI [4]
C1292777
UMLS CUI [5]
C0079774
Voltar ao início da página

Similar models

Eligibility Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-Type NCT01238159

1 Formulários
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
C1512693 (UMLS CUI)
Nasal Type Extranodal NK/T-Cell Lymphoma Biopsy
Item
patients were required to have a biopsy-proven diagnosis of nasal enktl
boolean
C0392788 (UMLS CUI [1,1])
C0005558 (UMLS CUI [1,2])
Age
Item
at least 18 years old
boolean
C0001779 (UMLS CUI [1])
Ann Arbor lymphoma staging system
Item
ann arbor stage ie or iie
boolean
C0432516 (UMLS CUI [1])
Measurable Disease
Item
measurable disease
boolean
C1513041 (UMLS CUI [1])
ECOG performance status | Life Expectancy
Item
eastern cooperative oncology group (ecog) performance status of 0-2 life expectancy greater than 12 weeks
boolean
C1520224 (UMLS CUI [1])
C0023671 (UMLS CUI [2])
Hematologic function | Hemoglobin measurement | Absolute neutrophil count | Platelet Count measurement
Item
adequate hematologic (hemoglobin > 9.0 g/dl, absolute neutrophil count > 1,500/ul and platelets > 100,000/ul)
boolean
C0221130 (UMLS CUI [1])
C0518015 (UMLS CUI [2])
C0948762 (UMLS CUI [3])
C0032181 (UMLS CUI [4])
Renal function | Creatinine measurement, serum | Creatinine clearance measurement
Item
renal (serum creatinine < 1.5 mg/dl, creatinine clearance > 50 ml/min)
boolean
C0232804 (UMLS CUI [1])
C0201976 (UMLS CUI [2])
C0373595 (UMLS CUI [3])
Liver function | Serum total bilirubin measurement | Aspartate aminotransferase measurement
Item
hepatic (total bilirubin < 2 times of upper limit of normal and aspartate transferase < 3 times of upper limit of normal) function
boolean
C0232741 (UMLS CUI [1])
C1278039 (UMLS CUI [2])
C0201899 (UMLS CUI [3])
Feature Histologic Compatible with Nasal Type Extranodal NK/T-Cell Lymphoma | Immunophenotype Histologic Compatible with Nasal Type Extranodal NK/T-Cell Lymphoma | Cytoplasmic CD3 Positive | CD20 Negative | CD56 Positive
Item
diagnosis of enktl is based on the presence of histological features and immunophenotypes compatible with enktl (e.g., cytoplasmic cd3+, cd20-, cd56+,
boolean
C2348519 (UMLS CUI [1,1])
C0205462 (UMLS CUI [1,2])
C0332290 (UMLS CUI [1,3])
C0392788 (UMLS CUI [1,4])
C0079611 (UMLS CUI [2,1])
C0205462 (UMLS CUI [2,2])
C0332290 (UMLS CUI [2,3])
C0392788 (UMLS CUI [2,4])
C3176950 (UMLS CUI [3,1])
C1514241 (UMLS CUI [3,2])
C0054946 (UMLS CUI [4,1])
C1513916 (UMLS CUI [4,2])
C0108754 (UMLS CUI [5,1])
C1514241 (UMLS CUI [5,2])
Positive Finding Molecule cytotoxic
Item
positive for cytotoxic molecules
boolean
C1514241 (UMLS CUI [1,1])
C0567416 (UMLS CUI [1,2])
C1511636 (UMLS CUI [1,3])
Positive Finding Epstein-Barr Virus In Situ Hybridization
Item
positive for ebv by in situ hybridization).
boolean
C1514241 (UMLS CUI [1,1])
C0014644 (UMLS CUI [1,2])
C0162788 (UMLS CUI [1,3])
Informed Consent
Item
informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Malignant Neoplasms
Item
prior or concomitant malignant tumors
boolean
C0006826 (UMLS CUI [1])
Medical Problem Preventing Protocol Compliance
Item
any coexisting medical problems of sufficient severity to prevent full compliance with the study protocol.
boolean
C1254481 (UMLS CUI [1,1])
C1292733 (UMLS CUI [1,2])
C0525058 (UMLS CUI [1,3])
Nasal Type Extranodal NK/T-Cell Lymphoma In addition to Anatomic Site Other | Nasal Type Extranodal NK/T-Cell Lymphoma In addition to Skin | Nasal Type Extranodal NK/T-Cell Lymphoma In addition to Gastrointestinal tract
Item
enktl with non-nasal sites such as skin or gastrointestinal tract was excluded even if it is localized.
boolean
C0392788 (UMLS CUI [1,1])
C0332287 (UMLS CUI [1,2])
C1515974 (UMLS CUI [1,3])
C0205394 (UMLS CUI [1,4])
C0392788 (UMLS CUI [2,1])
C0332287 (UMLS CUI [2,2])
C1123023 (UMLS CUI [2,3])
C0392788 (UMLS CUI [3,1])
C0332287 (UMLS CUI [3,2])
C0017189 (UMLS CUI [3,3])
Non-Hodgkin Lymphoma Subtype Other | Blastic NK-cell lymphoma | Natural Killer Cell Lymphoblastic Leukemia/Lymphoma | Aggressive natural killer-cell leukemia | Peripheral T-Cell Lymphoma
Item
other subtypes of non-hodgkin lymphoma (nhl), including myeloid/nk cell precursor acute leukemia, blastic nk cell lymphoma/precursor nk cell lymphoblastic leukemia, aggressive nk cell leukemia, and peripheral t cell lymphoma, unspecified, were excluded.
boolean
C0024305 (UMLS CUI [1,1])
C0449560 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,3])
C1301363 (UMLS CUI [2])
C2826059 (UMLS CUI [3])
C1292777 (UMLS CUI [4])
C0079774 (UMLS CUI [5])
Voltar ao início da página 

Contacto

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Ajuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial